Page last updated: 2024-11-04

sumatriptan and Alloxan Diabetes

sumatriptan has been researched along with Alloxan Diabetes in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research Excerpts

ExcerptRelevanceReference
"Tail flick latency, an index of hyperalgesia, was assessed using analgesiometer."1.35Possible role of spleen-derived factors, vanilloid receptors and calcitonin gene-related peptide in diabetes induced hyperalgesia in mice. ( Jaggi, AS; Khan, N; Singh, N, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, N1
Singh, N1
Jaggi, AS1

Other Studies

1 other study available for sumatriptan and Alloxan Diabetes

ArticleYear
Possible role of spleen-derived factors, vanilloid receptors and calcitonin gene-related peptide in diabetes induced hyperalgesia in mice.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:11

    Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Female; Hyperalgesia; Mal

2008